Structure Therapeutics (GPCR) Earnings Date, Estimates & Call Transcripts $16.33 -0.62 (-3.66%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$16.34 +0.01 (+0.03%) As of 04/3/2025 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Structure Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 8Before Market OpensEstimatedActual EPS (Feb. 27) -$0.22 Beat By $0.01 Consensus EPS (Feb. 27) -$0.23 Structure Therapeutics released Q4 2024 earnings on February 27, 2025, reporting an EPS of -$0.22, which beat analysts' consensus estimates of -$0.23 by $0.01. With a trailing EPS of -$0.79, Structure Therapeutics' earnings are expected to grow next year, from ($0.82) to ($0.62) per share. GPCR Upcoming EarningsStructure Therapeutics' next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules. Get Structure Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Structure Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGPCR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GPCR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Structure Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.24-$0.18-$0.22Q2 20253-$0.26-$0.18-$0.23Q3 20253-$0.29-$0.24-$0.27Q4 20253-$0.31$2.58$0.68FY 202512($1.10)$1.98($0.04) Remove Ads Structure Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------2/27/2025Q4 2024-$0.23-$0.22+$0.01-$0.22--8/8/2024--$0.23-$0.18+$0.05-$0.18--5/9/2024Q1 2024-$0.21-$0.19+$0.02-$0.19--3/8/2024Q4 2023-$0.21-$0.17+$0.04-$0.17--11/14/2023Q3 2023-$0.22-$0.21+$0.01-$0.21--8/10/2023Q2 2023-$0.19-$0.20 -$0.01-$0.20--5/11/2023Q1 2023-$0.34-$0.25+$0.09-$0.25-- Structure Therapeutics Earnings - Frequently Asked Questions When is Structure Therapeutics's earnings date? Structure Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on GPCR's earnings history. Did Structure Therapeutics beat their earnings estimates last quarter? In the previous quarter, Structure Therapeutics (NASDAQ:GPCR) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.01. Learn more on analysts' earnings estimate vs. GPCR's actual earnings. How much profit does Structure Therapeutics generate each year? Structure Therapeutics (NASDAQ:GPCR) has a recorded net income of -$89.62 million. GPCR has generated -$0.79 earnings per share over the last four quarters. What is Structure Therapeutics's EPS forecast for next year? Structure Therapeutics's earnings are expected to grow from ($0.82) per share to ($0.62) per share in the next year. More Earnings Resources from MarketBeat Related Companies PTC Therapeutics Earnings Date Zai Lab Earnings Date Organon & Co. Earnings Date Arcellx Earnings Date Avidity Biosciences Earnings Date Ultragenyx Pharmaceutical Earnings Date Rhythm Pharmaceuticals Earnings Date SpringWorks Therapeutics Earnings Date Akero Therapeutics Earnings Date Crinetics Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio? Remove Ads This page (NASDAQ:GPCR) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GPCR Stock Free GPCR Stock Alerts